Priyank J. Shah

Array ( [id] => 4100611 [patent_doc_number] => 06100072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Recombinant rabbit tissue factor based prothrombin time reagent' [patent_app_type] => 1 [patent_app_number] => 9/064378 [patent_app_country] => US [patent_app_date] => 1998-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5926 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100072.pdf [firstpage_image] =>[orig_patent_app_number] => 064378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4207645 [patent_doc_number] => 06077934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Contryphan peptides' [patent_app_type] => 1 [patent_app_number] => 9/061026 [patent_app_country] => US [patent_app_date] => 1998-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14970 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077934.pdf [firstpage_image] =>[orig_patent_app_number] => 061026 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4152948 [patent_doc_number] => 06103495 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Direct expression of peptides into culture media' [patent_app_type] => 1 [patent_app_number] => 9/060765 [patent_app_country] => US [patent_app_date] => 1998-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 29 [patent_no_of_words] => 14776 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103495.pdf [firstpage_image] =>[orig_patent_app_number] => 060765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636299 [patent_doc_number] => 06380360 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Polycystic kidney disease 1 gene and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/052469 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 102 [patent_no_of_words] => 60208 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380360.pdf [firstpage_image] =>[orig_patent_app_number] => 09052469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1266327 [patent_doc_number] => 06656681 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-02 [patent_title] => 'Polycystic kidney disease 12 gene and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/052262 [patent_app_country] => US [patent_app_date] => 1998-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 101 [patent_no_of_words] => 60249 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 521 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/656/06656681.pdf [firstpage_image] =>[orig_patent_app_number] => 09052262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4337506 [patent_doc_number] => 06333306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Pharmaceutical combination preparations containing erythropoietin and iron preparations' [patent_app_type] => 1 [patent_app_number] => 9/029859 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6573 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333306.pdf [firstpage_image] =>[orig_patent_app_number] => 029859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290673 [patent_doc_number] => 06180371 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Modified factor VIII' [patent_app_type] => 1 [patent_app_number] => 9/037601 [patent_app_country] => US [patent_app_date] => 1998-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 31257 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180371.pdf [firstpage_image] =>[orig_patent_app_number] => 037601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031102 [patent_doc_number] => 05994296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Human mutant tissue factor compositions useful as tissue factor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/035241 [patent_app_country] => US [patent_app_date] => 1998-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22406 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994296.pdf [firstpage_image] =>[orig_patent_app_number] => 035241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375892 [patent_doc_number] => 06303338 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Pancreas-derived plasminogen activator inhibitor' [patent_app_type] => 1 [patent_app_number] => 9/026408 [patent_app_country] => US [patent_app_date] => 1998-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 33440 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303338.pdf [firstpage_image] =>[orig_patent_app_number] => 026408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355924 [patent_doc_number] => 06174702 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-16 [patent_title] => 'Human pinch protein homolog' [patent_app_type] => 1 [patent_app_number] => 9/008465 [patent_app_country] => US [patent_app_date] => 1998-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19788 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/174/06174702.pdf [firstpage_image] =>[orig_patent_app_number] => 008465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4279389 [patent_doc_number] => 06281345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-28 [patent_title] => 'Parasite astacin metalloendopeptidase nucleic acid molecules and uses thereof' [patent_app_type] => 1 [patent_app_number] => 9/003570 [patent_app_country] => US [patent_app_date] => 1998-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36601 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/281/06281345.pdf [firstpage_image] =>[orig_patent_app_number] => 003570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933955 [patent_doc_number] => 05972688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'HT.sub.m4 methods of treatment and assays, agonists and antagonists' [patent_app_type] => 1 [patent_app_number] => 8/994578 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14639 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972688.pdf [firstpage_image] =>[orig_patent_app_number] => 994578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4290444 [patent_doc_number] => 06180359 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-30 [patent_title] => 'Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilase' [patent_app_type] => 1 [patent_app_number] => 8/957621 [patent_app_country] => US [patent_app_date] => 1997-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 11774 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/180/06180359.pdf [firstpage_image] =>[orig_patent_app_number] => 957621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4163627 [patent_doc_number] => 06139838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Tissue plasminogen activator medicinal composition' [patent_app_type] => 1 [patent_app_number] => 8/923999 [patent_app_country] => US [patent_app_date] => 1997-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4432 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/139/06139838.pdf [firstpage_image] =>[orig_patent_app_number] => 923999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933839 [patent_doc_number] => 05972681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Calcium-requiring prothrombin activator' [patent_app_type] => 1 [patent_app_number] => 8/894403 [patent_app_country] => US [patent_app_date] => 1997-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 3279 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972681.pdf [firstpage_image] =>[orig_patent_app_number] => 894403 [rel_patent_id] =>[rel_patent_doc_number] =>)